Botella de Maglia J, Espacio Casanovas A
Unidad de Medicina Intensiva, Hospital La Fe, Valencia.
Rev Clin Esp. 1998 Aug;198(8):509-13.
Six patients with severe and complicated falciparum malaria (6.7 +/- 2.7 WHO criteria) were admitted to our Intensive Care Unit. All patients acquired the disease while travelling in tropical Africa without appropriate chemoprophylaxis. The clinical manifestations included hyperpyrexia (all patients), chills (4), sweating (2), asthenia (3), anorexia (2), headache (1), arthralgias (1), vomiting (4), diarrhoea or abdominal discomfort (3), jaundice (2) and disturbances of consciousness (4). All patients had anemia, thrombocytopenia, hyponatremia, hypoproteinemia, hypoalbuminemia, hypocalcemia and acute renal failure, in one case associated with anuria. A low grade parasitemia was observed in two patients and a high grade parasitemia (20%-58% of erythrocytes) in four. Exchange transfusion was performed only in high parasitemic patients and all of them survived. All patients were treated with quinine, a sulfonamide and pyrimethamine. Additionally, five patients received oxytetracycline, doxycycline or clindamycin. Three patients required hemodyalisis. Five patients had delirium, coma or seizures. All patients had at least one sign of hepatic impairment: liver enlargement, jaundice or increased bilirubin or aminotransferase levels. Two patients had spleen enlargement. Laboratory findings suggested disseminated intravascular coagulation in four patients. Four patients developed pulmonary changes and three of them required mechanical ventilation. A Swan-Ganz catheter was placed in four patients. In three of them (two with pulmonary edema) the pulmonary capillary wedge pressure was initially increased, which suggested a cardiogenic or hypervolemia mechanism, but soon returned to normal level. One patient with low grade parasitemia died because of adult respiratory distress syndrome after 18 days. In our series, the degree of parasitemia was not related to the severity of the disease.
6例患有严重复杂恶性疟原虫疟疾(根据世界卫生组织标准评分为6.7±2.7)的患者被收治入我们的重症监护病房。所有患者均在热带非洲旅行期间未进行适当化学预防而感染该病。临床表现包括高热(所有患者)、寒战(4例)、出汗(2例)、乏力(3例)、厌食(2例)、头痛(1例)、关节痛(1例)、呕吐(4例)、腹泻或腹部不适(3例)、黄疸(2例)以及意识障碍(4例)。所有患者均有贫血、血小板减少、低钠血症、低蛋白血症、低白蛋白血症、低钙血症以及急性肾衰竭,其中1例伴有无尿。2例患者观察到低水平寄生虫血症,4例患者观察到高水平寄生虫血症(红细胞的20%-58%)。仅对高水平寄生虫血症患者进行了换血治疗,所有这些患者均存活。所有患者均接受了奎宁、一种磺胺类药物和乙胺嘧啶治疗。此外,5例患者接受了土霉素、强力霉素或克林霉素治疗。3例患者需要血液透析。5例患者出现谵妄、昏迷或癫痫发作。所有患者至少有一项肝功能损害体征:肝脏肿大、黄疸或胆红素或转氨酶水平升高。2例患者脾脏肿大。实验室检查结果提示4例患者发生弥散性血管内凝血。4例患者出现肺部改变,其中3例需要机械通气。4例患者放置了Swan-Ganz导管。其中3例(2例伴有肺水肿)最初肺毛细血管楔压升高,提示心源性或血容量过多机制,但很快恢复到正常水平。1例低水平寄生虫血症患者在18天后因成人呼吸窘迫综合征死亡。在我们的系列病例中,寄生虫血症程度与疾病严重程度无关。